Academy Capital Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-66,733
Closed -$6.59M 38
2017
Q3
$6.59M Sell
66,733
-846
-1% -$82K 1.85% 21
2017
Q2
$6.84M Sell
67,579
-612
-0.9% -$66K 1.89% 22
2017
Q1
$7.88M Sell
68,191
-900
-1% -$105K 2.15% 21
2016
Q4
$8.29M Sell
69,091
-189
-0.3% -$20.9K 2.26% 19
2016
Q3
$7.78M Sell
69,280
-109
-0.2% -$12.6K 2.07% 23
2016
Q2
$8.6M Sell
69,389
-5,390
-7% -$651K 2.21% 23
2016
Q1
$8.4M Sell
74,779
-1,472
-2% -$153K 2.04% 23
2015
Q4
$8.29M Sell
76,251
-9,023
-11% -$1.03M 1.88% 24
2015
Q3
$8.51M Buy
85,274
+635
+0.8% +$69.1K 1.68% 25
2015
Q2
$9.65M Sell
84,639
-6,515
-7% -$790K 2% 22
2015
Q1
$9.52M Buy
+91,154
New +$9.71M 1.87% 24

Other funds holding CLB

Academy Capital Management's CLB Position: Q4 2017 in Review

Academy Capital Management sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 66,733 shares — an estimated $6.59M sold.

Academy Capital Management first reported a position in CLB in Q1 2015 and held it in 11 quarters. The position peaked at $9.65M in Q2 2015. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Academy Capital Management reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Academy Capital Management sold 66,733 Core Laboratories shares in Q4 2017, an estimated $6.59M.
  • Academy Capital Management first reported a position in Core Laboratories in Q1 2015 and held it in 11 quarters.
  • Academy Capital Management's Core Laboratories position peaked at $9.65M in Q2 2015.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Academy Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.